Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03366272
Title Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients (NIVEAU)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universität des Saarlandes
Indications

non-Hodgkin lymphoma

Therapies

Gemcitabine + Nivolumab + Oxaliplatin + Rituximab

Gemcitabine + Oxaliplatin + Rituximab

Age Groups: senior | adult
Covered Countries FRA | DEU | BEL | AUT


No variant requirements are available.